Roche China R&D Center Chief Scientific Officer Li Chen On Being a Pioneer in China (An Interview, Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Chen discusses how Roche is approaching R&D differently in China and the role that China will play in the global pharmaceutical arena.
You may also be interested in...
Roche China R&D Center Chief Scientific Officer Li Chen On Being a Pioneer in China: An Interview With PharmAsia News (Part 1 of 2)
Swiss-headquartered Roche, the first multinational pharmaceutical outfit to establish a research and development center in China, recently established one of its Pharma Partnering groups in Shanghai. Roche's China CSO Li Chen sat down with PharmAsia News recently to talk about how the company is approaching R&D in the region and evolving in tandem with the pharmaceutical landscape in China. Chen is also a member of the networking organization BayHelix, which links Chinese life sciences executives.
Roche Global Licensing Director Stella Xu and Business Development Director Frank Grams On Seeking More Innovation In China And Korea: An Interview With PharmAsia News (Part 2 of 2)
Roche recently expanded its investment in innovation in Asia by opening its fourth Global Partnering office in Shanghai. Roche Global Licensing Director Stella Xu and Business Development Director Frank Grams sat down with PharmAsia News' Shanghai Bureau to talk about the mission of the newly established partnering site and Roche's partnering strategies in Asia.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.